Dog /

Breed profile · FDA CVM July 2026 extract

Mountain Cur adverse-event record

Adverse-event filings for Mountain Cur (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#140 of 510
by report volume (all breeds)
510
FDA CVM reports on file
1.6%
death-coded share of reports
#269 of 275
by death-coded share (≥50 reports)

How the 510 reports break down

By recorded gender -- every report on file for Mountain Cur, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 54 40.5 27 13.5 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Mountain Cur drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Mountain Cur ranks #140 of 510 by total reports (510) and #269 of 275 by death-coded share (1.6%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#140
This breed, reports of 510
#269
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Mountain Cur has 510 reports now versus 500 in that prior snapshot: 10 more (2.0%).

Report change
+10
Death-coded reports
+1
Death-coded share
+0.2 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Mountain Cur changes

Total Reports

510

Above-median volume

Deaths Reported

8

of 510 reports

Death-coded share of reports

1.6%

Lowest death-coded share

Avg Age at Report

3.8 yr

22.7 kg avg weight

Breed Safety Scorecard

B- (67/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate A+
1.6%

Share of reports coded as a fatality

Euthanasia rate A+
0.6%

Share of reports resulting in euthanasia

Full recovery rate F
16.1%

Share of reports coded "Recovered/Normal"

5-year trend C+
-3%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Mountain Cur death-coded reports 1.6%
Cross-breed median

1.6% of 510 mountain cur reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Mountain Cur's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

2% 2nd percentile Higher share than 2% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Mountain Cur 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 22.7 kg (50.1 lbs)

Top Reported Reactions

Lack of efficacy (endoparasite) - heartworm 204
INEFFECTIVE, HEARTWORM LARVAE 63
Vomiting 58
Lack of efficacy (endoparasite) - hookworm 29
Lack of efficacy - NOS 23
Emesis 23
Lethargy (see also Central nervous system depression in 'Neurological') 18
Cardiac disorder NOS 14

Most Referenced Drugs

Milbemycin Oxime + Spinosad 130
Moxidectin 100
Ivermectin + Pyrantel As Pamoate Salt 93
Milbemycin Oxime + Praziquantel 63
Pyrantel Pamoate;Sarolaner 63
Spinosad 13
Fluralaner 13.64% 12-Week Chew 12
Ivermectin 11

Outcome Breakdown

Ongoing
209 (40.7%)
Outcome Unknown
165 (32.2%)
Recovered/Normal
82 (16.0%)
Recovered with Sequela
49 (9.6%)
Died
5 (1.0%)
Euthanized
3 (0.6%)

Gender Distribution

Female 260 (51.0%)
Male 243 (47.6%)
Unknown 5 (1.0%)
Mixed 2 (0.4%)

Reports by Year

Year Reports Trend
2011 2
2012 5
2013 24
2014 28
2015 30
2016 31
2017 22
2018 32
2019 47
2020 49
2021 35
2022 53
2023 54
2024 54
2025 34
2026 10

Mountain Cur: low death-coded share in the FDA CVM extract

Signature read: Mountain Cur's 1.6% death-coded share is in the lower third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Mountain Cur sits at #140 of 510 by report volume among all breeds and #116 of 298 among dog breeds, with 510 reports and 8 (1.6%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #269 of 275. Mean age at report: 3.8 years, average weight 22.7 kg (50.1 lbs).

Top reported signs: Lack of efficacy (endoparasite) - heartworm (204), INEFFECTIVE, HEARTWORM LARVAE (63), Vomiting (58). Most-referenced drug: Milbemycin Oxime + Spinosad (130 reports), followed by Moxidectin (100) and Ivermectin + Pyrantel As Pamoate Salt (93).

Outcome coding on 513 status-recorded reports is dominated by Ongoing (40.7%). Annual submissions ranged 2-2,026 across 16 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Mountain Cur drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (1.6% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (22.7 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Mountain Cur?
There are 510 adverse event reports involving Mountain Cur in the FDA database, of which 8 were death-coded (1.6% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Mountain Cur ranks #140 of 510 by report volume among all breeds PlainBreed indexes (#116 of 298 among dog breeds).
Where does Mountain Cur sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Mountain Cur is #140 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #116 of 298. Among breeds with at least 50 reports, its death-coded share ranks #269 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Mountain Cur?
The most commonly reported adverse reactions for Mountain Cur are Lack of efficacy (endoparasite) - heartworm (204 reports), INEFFECTIVE, HEARTWORM LARVAE (63 reports), Vomiting (58 reports), Lack of efficacy (endoparasite) - hookworm (29 reports), Lack of efficacy - NOS (23 reports).
What drugs are most frequently associated with Mountain Cur adverse events?
The drugs most frequently referenced in Mountain Cur adverse event reports are Milbemycin Oxime + Spinosad (130 reports), Moxidectin (100 reports), Ivermectin + Pyrantel As Pamoate Salt (93 reports), Milbemycin Oxime + Praziquantel (63 reports), Pyrantel Pamoate;Sarolaner (63 reports).
What is the average age of Mountain Cur in adverse event reports?
The average age of Mountain Cur at the time of adverse event reports is 3.8 years, with an average weight of 22.7 kg (50.1 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Mountain Cur (Dog), extract as of July 2026 extract. 510 reports · 8 death-coded (1.6% of reports, not a mortality rate) · #140 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →